Tag: progestin
Articles
- How does birth control pill use influence breast cancer risk?
- Latest research concerning breast density and breast cancer
- Latest research on hormone replacement therapy and breast cancer
News
- Apigenin may prevent breast cancer that develops in response to progestin
- Birth control pills with levonorgestrel as the progestin increase risk of breast cancer
- Breast tenderness from combination hormone replacement therapy (HRT) predicts breast cancer
- Combination HRT doubles breast cancer risk among women with breast tenderness
- Combined HRT increase risk of lymph node positive breast cancer
- Drop in hormone replacement therapy use explains part of decline in breast cancer rates
- Estrogen only and combined HRT both increase risk of breast cancer
- High circulating hormones increase risk of breast cancer for postmenopausal women
- HRT increases risk of breast cancer, especially for those with dense breasts
- Less HRT use after 2002 translated into fewer breast cancer cases among Canadian women
Foods
Studies
- Age and Menopausal Effects of Hormonal Birth Control and Hormone Replacement Therapy in Relation to Breast Cancer Risk
- Apigenin Induces Apoptosis and Blocks Growth of Medroxyprogesterone Acetate-Dependent BT-474 Xenograft Tumors
- Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats
- Breast Cancer Incidence and Hormone Replacement Therapy in Canada
- Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use
- Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials
- Change in mammographic density with estrogen and progestin therapy: A measure of breast cancer risk in the Women’s Health Initiative
- Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
- Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors
- Dual Estrogen Effects on Breast Cancer: Endogenous Estrogen Stimulates, Exogenous Estrogen Protects. Further Investigation of Estrogen Chemoprevention Is Warranted
- Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20-44 years of age
- Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the Cyclin D1/MYC promoters
- Hot flashes, hormone therapy, and breast cancer risk: The Women’s Health Initiative Clinical Trials
- Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European prospective investigation into cancer and nutrition (EPIC)
- Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women
- Risk factors for postmenopausal breast cancer defined by estrogen and progesterone receptor status: The multiethnic cohort
- Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial